The Patent Finder

Novel GLP-1 Analogues

Sun Pharmaceutical Industries, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 16/376,190, filed Apr 5, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,242,373Novel GLP-1 Analogues
In force
 · High confidence
UsedRemaining
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
US 11,447,535Novel GLP-1 Analogues
In force
 · High confidence
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
US 11,866,477Novel GLP-1 Analogues
In force
 · High confidence
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
US 11,873,328Novel GLP-1 Analogues
In force
 · High confidence
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
US 12,421,289GLP-1 Analogues
In force
 · High confidence
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
US 11,485,766Novel GLP-1 Analogues
In force
 · High confidence
Sun Pharmaceutical Industries LimitedIn forceHigh confidence
Application 18/667,531Novel GLP-1 Analogues
Pending
Not granted
Sun Pharmaceutical Industries limitedPendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Sun Pharmaceutical Industries, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited